Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248792 | 8238111 | F | 8248792-8 | 20111004 | 20120323 | 20120331 | EXP | PHHY2011CH097849 | NOVARTIS PHARMACEUTICAL CORPORATION | 37 | YR | F | Y | 99 | KG | 20120327 | MD | SWITZERLAND |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248792 | 1019282908 | PS | GILENYA | 1 | 0.5 MG, QD | 022527 | |||||
| 8248792 | 1019282910 | C | DEPO-PROVERA 150 | 2 | |||||||
| 8248792 | 1019282909 | C | FEXOFENADINE HCL | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248792 | 1019282908 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248792 | LT |
| 8248792 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 8248792 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 8248792 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
| 8248792 | LIVER DISORDER |
| 8248792 | ALANINE AMINOTRANSFERASE INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248792 | 1019282908 | 20110913 | 20111004 | 22 | DAY |